Nicollet Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
5,532
+28
+0.5% +$13.4K 0.86% 34
2026
Q1
$2.71M Sell
5,504
-196
-3% -$106K 0.93% 31
2025
Q4
$3.3M Buy
5,700
+25
+0.4% +$14.1K 1.05% 29
2025
Q3
$2.75M Sell
5,675
-125
-2% -$58.2K 0.9% 31
2025
Q2
$2.35M Sell
5,800
-232
-4% -$97K 0.79% 35
2025
Q1
$3M Buy
6,032
+265
+5% +$144K 1.06% 33
2024
Q4
$3M Sell
5,767
-225
-4% -$124K 1.03% 33
2024
Q3
$3.71M Buy
5,992
+11
+0.2% +$6.51K 1.28% 29
2024
Q2
$3.31M Sell
5,981
-119
-2% -$68.2K 1.23% 28
2024
Q1
$3.54M Buy
6,100
+1,005
+20% +$564K 1.31% 27
2023
Q4
$2.7M Sell
5,095
-1,098
-18% -$531K 1.1% 32
2023
Q3
$3.13M Buy
6,193
+57
+0.9% +$30.4K 1.4% 28
2023
Q2
$3.2M Buy
+6,136
New +$3.31M 1.43% 25

Other funds holding TMO

Nicollet Investment Management's TMO Position: Q2 2026 in Review

Nicollet Investment Management increased its Thermo Fisher Scientific (TMO) stake by 0.51% in Q2 2026, buying an estimated $13.4K and bringing the position to 5,532 shares worth $2.77M. The position accounts for 0.86% of the portfolio, ranked #34.

Nicollet Investment Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.71M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nicollet Investment Management held 5,532 shares of Thermo Fisher Scientific worth $2.77M as of Q2 2026.
  • Nicollet Investment Management bought 28 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.4K.
  • Thermo Fisher Scientific made up 0.86% of Nicollet Investment Management's portfolio in Q2 2026, its #34 holding.
  • Nicollet Investment Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • Nicollet Investment Management's Thermo Fisher Scientific position peaked at $3.71M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nicollet Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.